Cancer rehabilitation: Recommendations for integrating exercise programming in the clinical practice setting

Current Cancer Therapy Reviews

Volumn 2, Issue 4, 2006, Pages 351-360

  McNeely, Margaret L ^a   Peddle, Carolyn J ^a   Parliament, Matthew ^a   Courneya, Kerry S ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cancer survivors; Cardiac disease; Chemotherapeutic agents; Exercise trials; Muscular strength

Indexed keywords

ANDROGEN; ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; CISPLATIN; CORTICOSTEROID DERIVATIVE; CYTOKINE; DOXORUBICIN; INTERFERON; METHOTREXATE; PACLITAXEL; PREDNISONE; THALIDOMIDE; VINCRISTINE;

AEROBIC EXERCISE; ANEMIA; ARTHRALGIA; AUTONOMIC NEUROPATHY; BODY WEIGHT DISORDER; BONE DISEASE; CANCER PAIN; CANCER PATIENT; CANCER REHABILITATION; CANCER SURVIVOR; CARDIOMYOPATHY; CARDIOTOXICITY; CLINICAL STUDY; CLINICAL TRIAL; COGNITIVE DEFECT; COMMUNITY PROGRAM; COMORBIDITY; CONGESTIVE HEART FAILURE; CRANIAL NEUROPATHY; DEPRESSION; DIPLOPIA; DRUG FATALITY; DYSPNEA; ECG ABNORMALITY; EXERCISE TEST; FATIGUE; HEALTH CARE DELIVERY; HEALTH PROGRAM; HEART ARRHYTHMIA; HEART DISEASE; HEART INFARCTION; HEMATOLOGIC MALIGNANCY; HUMAN; INFECTION; JOINT MOBILITY; KINESIOTHERAPY; LUNG TOXICITY; MALIGNANT NEOPLASTIC DISEASE; META ANALYSIS; MOOD DISORDER; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; MUSCLE EXERCISE; MUSCLE STRENGTH; MUSCLE WEAKNESS; MUSCULOSKELETAL DISEASE; MYOPATHY; NAUSEA; NEUROPATHIC PAIN; NEUROTOXICITY; OBESITY; ORTHOSTATIC HYPOTENSION; OSTEOPENIA; PATIENT PARTICIPATION; PATIENT SAFETY; PERICARDITIS; PERIPHERAL NEUROPATHY; PHYSICAL ACTIVITY; POSTOPERATIVE PAIN; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROFESSIONAL STANDARD; RANGE OF MOTION; RESPIRATORY TRACT DISEASE; RESUSCITATION; REVIEW; SOMNOLENCE; SUPRAVENTRICULAR TACHYCARDIA; SYSTEMATIC REVIEW; TREATMENT PLANNING; XEROSTOMIA;

EID: 33750729930     PISSN: 15733947     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339406778699187     Document Type: Review

References (63)

1. Currie GP, Douglas JG. ABC of chronic obstructive pulmonary disease. Non-pharmacological management. BMJ 2006; 332: 1379-81.
2. Lloyd-Williams F, Mair FS, Leitner M. Exercise training and heart failure: A systematic review of current evidence. Br J Gen Pract 2002; 52: 47-55.
3. Thomas DE, Elliott EJ, Naughton GA. Exercise for type 2 diabetes mellitus. Cochrane Database Syst Rev 2006; 3: CD002968.
4. Floyd JD, Nguyen DT, Lobins RL, et al. Cardiotoxicity of cancer therapy. J Clin Oncol 2005; 23: 7685-96.
5. Hewitt M, Rowland JH, Yancik R. Cancer survivors in the united states: Age, health, and disability. J Gerontol A Biol Sci Med Sci 2003; 58: 82-91.
6. De Cicco M, Bortolussi R, Fantin D, et al. Supportive therapy of elderly cancer patients. Crit Rev Oncol Hematol 2002; 42: 189-211.
7. Yeager K, McGuire, BD, Sheidler, VR. In: Yarboo CH FM, Goodman K Groenwald SL Ed, Cancer Nursing: Principles and Practice. Sudbury, Jones and Bartlett. 2000.
8. Portenoy RK, Itri LM. Cancer-related fatigue: Guidelines for evaluation and management. Oncologist 1999; 4: 1-10.
9. Berger A. Treating fatigue in cancer patients. Oncologist 2003; 8 Suppl 1: 10-4.
10. Jantarakupt P, Porock D. Dyspnea management in lung cancer: Applying the evidence from chronic obstructive pulmonary disease. Oncol Nurs Forum 2005; 32: 785-97.
11. Ganz P, Reuben, BD. In: Hunter C, Johnson, KA, Muss, HB Ed, Cancer in the elderly. New York, Marcel Dekker, Inc. 2000; 541-42.
12. Raison CL, Miller AH. Depression in cancer: New developments regarding diagnosis and treatment. Biol Psychiatry 2003; 54: 283-94.
13. Lovejoy NC, Tabor D, Deloney P. Cancer-related depression: Part ii - neurologic alterations and evolving approaches to psychopharmacology. Oncol Nurs Forum 2000; 27: 795-808; quiz 9-10.
14. Valente SM, Saunders JM. Diagnosis and treatment of major depression among people with cancer. Cancer Nurs 1997; 20: 168-77.
15. Goodwin PJ, Ennis M, Pritchard KI, et al. Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis. J Clin Oncol 1999; 17: 120-9.
16. Segal RJ, Reid, RD, Courneya, KS, et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 2003; 21: 1653-9.
17. Higano CS. Side effects of androgen deprivation therapy: Monitoring and minimizing toxicity. Urology 2003; 61: 32-8.
18. Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA 1999; 282: 1523-9.
19. Ardies CM. Exercise, cachexia, and cancer therapy: A molecular rationale. Nutr Cancer 2002; 42: 143-57.
20. Balducci L. Geriatric oncology. Crit Rev Oncol Hematol 2003; 46: 211-20.
21. Sadler GR, Stoudt A, Fullerton JT, et al. Managing the oral sequelae of cancer therapy. Medsurg Nurs 2003; 12: 28-36.
22. Sullivan CA, Haddad RI, Tishler RB, Mahadevan A, Krane JF. Chemoradiation-induced cell loss in human submandibular glands. Laryngoscope 2005; 115: 958-64.
23. Batchelor TT, Taylor LP, Thaler HT, Posner JB, DeAngelis LM. Steroid myopathy in cancer patients. Neurology 1997; 48: 1234-8.
24. Croarkin E. Osteopenia in the patient with cancer. Phys Ther 1999; 79: 196-201.
25. Moore I, Hobbie, W. In: Yarboo CH FM, Goodman M, Groenwald SL Ed, Cancer Nursing: Principles and Practice. 5th ed. New York, Jones and Bartlett. 2000; 567-615.
26. Corbo M, Balmaceda C. Peripheral neuropathy in cancer patients. Cancer Invest 2001; 19: 369-82.
27. Armstrong T, Almadrones L, Gilbert MR. Chemotherapy-induced peripheral neuropathy. Oncol Nurs Forum 2005; 32: 305-11.
28. Hausheer FH, Schilsky RL, Bain S, Berghorn EJ, Lieberman F. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Semin Oncol 2006; 33: 15-49.
29. Penedo FJ, Schneiderman N, Dahn JR, Gonzalez JS. Physical activity interventions in the elderly: Cancer and comorbidity. Cancer Invest 2004; 22: 51-67.
30. American College of Sports Medicine. ACSM's guidelines for physical activity. 7th ed. Baltimore: Lippincott William & Wilkins; 2006.
31. Calle EE, Kaaks R. Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4: 579-91.
32. Knols R, Aaronson NK, Uebelhart D, Fransen J, Aufdemkampe G. Physical exercise in cancer patients during and after medical treatment: A systematic review of randomized and controlled clinical trials. J Clin Oncol 2005; 23: 3830-42.
33. McNeely ML, Campbell KL, Rowe BH, et al. Effects of exercise on breast cancer patients and survivors: A systematic review and meta-analysis. CMAJ 2006; 175: 34-41.
34. Schmitz KH, Holtzman J, Courneya KS, et al. Controlled physical activity trials in cancer survivors: A systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2005; 14: 1588-95.
35. Stevinson C, Lawlor, DA, Fox, KA. Exercise interventions for cancer patients: Systematic review of controlled trials. Canc Causes Control 2004; 15: 1035-56.
36. Conn VS, Hafdahl AR, Porock DC, McDaniel R, Nielsen PJ. A meta-analysis of exercise interventions among people treated for cancer. Support Care Cancer 2006; 14: 699-712.
37. Brown JK, Byers T, Doyle C, et al. Nutrition and physical activity during and after cancer treatment: An American Cancer Society guide for informed choices. CA Cancer J Clin 2003; 53: 268-91.
38. Courneya KS, Friedenreich, CM. Relationship between exercise during treatment and current quality of life among survivors of breast cancer. J Psychosoc Oncol 1997; 15: 35-57.
39. Pinto BM, Maruyama NC, Engebretson NC, Engebretson TO, Thebarge RW. Participation in exercise, mood, and coping in survivors of early stage breast cancer. J Psychosoc Oncol 1998; 16: 45-58.
40. Pinto BM, Trunzo JJ, Reiss P, Shin S. Exercise participation after diagnosis of cancer: Trends and effects on quality of life. Psychooncology 2002; 11: 389-400.
41. Blanchard CM, Courneya KS, Rodgers WM, Murnagham DM. Determinants of exercise intention and behavior in survivors of breast and prostate cancer: An application of the theory of planned behavior. Cancer Nurs 2002; 25: 88-95.
42. Jones LW, Courneya KS. Exercise counseling and programming preferences of cancer survivors. Cancer Practice 2002; 10: 208-15.
43. Courneya KS, Friedenreich CM. Relationship between exercise pattern across the cancer experience and current quality of life in colorectal cancer survivors. J Altern Complemen Med 1997; 3: 215-26.
44. Vallance JHK, Jones LW, Reiman T, Exercise preference among a population-based sample of non-hodgkin's lymphoma survivors. Eur J Cancer Care 2006; 14: 34-43.
45. Cooper H. The role of physical activity in the recovery from breast cancer. Melpomene Journal 1995; 14: 18-20.
46. Jones LW, Courneya KS, Vallance JKH et al. Association between exercise and quality of life in multiple myeloma cancer survivors. Support Care Cancer 2004; 12: 780-8.
47. Bouchard C, Shepard RJ. In: Bouchard C, Shepard RJ, Stephens T Ed, Physical activity, fitness, and health: International proceedings and consensus statement. Champaign, IL, Human Kinetics. 1994; 77-88.
48. Courneya KS, Jones LW, Fairey AS, et al. Physical activity in cancer survivors: Implications for recurrence and mortality. Cancer Therapy 2004; 2: 1-12.
49. Balady GJ, Chaitman B, Driscoll D, et al. Recommendations for cardiovascular screening, staffing, and emergency policies at health/ fitness facilities. Circulation 1998; 97: 2283-93.
50. McArdle WD, Katch FI, Karch VL. Exercise physiology. Baltimore: Lippincott Williams & Wilkins; 2001.
51. Schneider C, Dennehy, CA, Carter SD. Exercise and cancer recovery. Champaign: Human Kinetics; 2003.
52. Humpel N, Iverson DC. Review and critique of the quality of exercise recommendations for cancer patients and survivors. Support Care Cancer 2005; 13: 493-502.
53. Butler RN, Davis R, Lewis CB, Nelson ME, Strauss E. Physical fitness: Exercise prescription for older adults. Geriatrics 1998; 53 (Sept): 52-4.
54. Kuster MS. Exercise recommendations after joint replacement: A review of current literature and proposal of scientifically based guidelines. Sports Med 2002; 32: 433-45.
55. Courneya K, Mackey JR, Quinney H. In: Myers J, Herbert, W, Humphrey, R Ed, ACSM's resources for clinical exercise physiology: Musculoskeletal, neuromusclur, neoplastic, immunologic, and hematologic conditions. Philadelphia, Am Coll Sports Med 2002; 179-91.
56. Galantino ML, Capito L, Kane RJ, et al. The effects of tai chi and walking on fatigue and body mass index in women living with breast cancer: A pilot study. Rehabil Oncol 2003; 21.
57. Mustian KM, Katula JA, Zhao H. A pilot study to assess the influence of tai chi chuan on functional capacity among breast cancer survivors. J Support Oncol 2006; 4: 139-45.
58. Courneya KS, Mackey JR, Jones LW. Coping with cancer: Can exercise help? Physician Sports Med 2000; 28.
59. Fletcher GF, Balady GJ, Amsterdam EA, et al. Exercise standards for testing and training: A statement for healthcare professionals from the American Heart Association. Circulation 2001; 104: 1694-740.
60. Courneya KS, Friedenreich CM. Utility of the theory of planned behavior for understanding exercise during breast cancer treatment. Psychooncology 1999; 8: 112-22.
61. Courneya KS, Friedenreich CM. Determinants of exercise during colorectal cancer treatment: An application of the theory of planned behavior. Oncol Nurs Forum 1997; 24: 1715-23.
62. Leddy SK. Incentives and barriers to exercise in women with a history of breast cancer. Oncol Nurs Forum 1997; 24: 885-90.
63. Courneya KS, Friedenreich CM, Arthur K, Bobick TM. Understanding exercise motivation in colorectal cancer patients: A prospective study using the theory of planned behavior. Rehabil Psychol 1999; 44: 68-84.